View up-to-date information on Cytodyn Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
IL294113A | Application | Ccr5 binding agent for treatment of ccr5 positive metastatic cancer | A61K2039/505; A61K2039/507; A61K2300/00; A61K31/167; A61K31/282; A61K31/337; A61K31/4025; A61K31/4196; A61K31/4545; A61K31/499; A61K31/506; A61K39/395; A61K39/39541; A61K39/3955; A61K39/39558; A61P35/04; C07K16/2866; C07K2317/24; C07K2317/565; C07K2317/76 | August 01, 2022 |
AU2021207851A1 | Application | CCR5 binding agent for treatment of CCR5 positive metastatic cancer | A61K2039/505; A61K2039/507; A61K2300/00; A61K31/167; A61K31/282; A61K31/337; A61K31/4025; A61K31/4196; A61K31/4545; A61K31/499; A61K31/506; A61K39/395; A61K39/39541; A61K39/3955; A61K39/39558; A61P35/04; C07K16/2866; C07K2317/24; C07K2317/565; C07K2317/76 | July 14, 2022 |
EP4007603A1 | Application | VERFAHREN ZUR BEHANDLUNG ODER VORBEUGUNG VON KREBS DURCH VERABREICHUNG VON ANTI-CCR5-REZEPTORMITTELN | A61K2039/505; A61K39/3955; A61K45/06; A61P35/04; C07K16/2866; C07K2317/24; C07K2317/76 | June 08, 2022 |
BR112022001037A2 | Application | Métodos para tratamento ou prevenção de cânceres envolvendo a administração de agentes receptores anti-ccr5 | A61K2039/505; A61P35/04; C07K16/2866; C07K2317/24; C07K2317/76 | June 07, 2022 |
US20220162327A1 | Application | ANTI-CCR5 AGENTS AND METHODS OF TREATMENT THAT BLOCK CANCER METASTASIS OR ENHANCE CELL DEATH INDUCED BY DNA DAMAGING CHEMOTHERAPY | A61K2039/545; A61K31/704; A61P35/00; C07K16/2866 | May 26, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward